School of Pharmacy, Pittsburgh, PA, USA.
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ann Pharmacother. 2021 Dec;55(12):1474-1485. doi: 10.1177/10600280211009567. Epub 2021 Apr 15.
Goals of managing patients with acute kidney injury (AKI) are mitigating disease progression and ensuring safety while providing supportive care because no effective treatment exists. One strategy recommended in guidelines to meet these goals is optimizing medication management. Unfortunately, guideline implementation appears to be lacking as observed by the frequent occurrence of medication errors and adverse drug events.
To address this performance gap in the care of hospitalized patients receiving nephrotoxins and renally eliminated drugs, we sought to provide a potential intervention based on theory-informed behavior change.
Formative research with a qualitative analysis identifying what needs to change in patient care was completed by obtaining clinician opinion and expert opinion and reviewing the published literature. Frontline providers, including 8 physicians, 4 pharmacists, and a multiprofessional group of authors, provided insight into possible barriers to appropriate prescribing. Capability, Opportunity, Motivation and Behavior model and Theoretical Domain Framework were applied to characterize behavior change interventions and inform a potential implementation intervention for changing inappropriate prescribing behaviors.
Lack of knowledge about appropriate drug management in patients at risk for adverse outcomes was provided as a major barrier. Other reported barriers included a lack of: (1) tools to assist with drug management, (2) motivation to make changes, (3) routinization, and (4) an accountable clinician.
Assigning a designated clinician to execute a stepwise, routine care process following the checklist provided is a recommended intervention to overcome barriers. The intended impact is behavior change that reduces inappropriate prescribing.
急性肾损伤 (AKI) 患者管理的目标是减轻疾病进展并确保安全性,同时提供支持性护理,因为目前尚无有效的治疗方法。指南中建议的一项策略是优化药物管理,以实现这些目标。然而,正如经常发生的药物错误和药物不良事件所表明的那样,指南的实施似乎存在差距。
为了解决接受肾毒性药物和经肾脏排泄的药物的住院患者护理中的这一绩效差距,我们试图提供一种基于理论指导的行为改变的潜在干预措施。
通过获取临床医生的意见和专家意见以及审查已发表的文献,进行了定性分析的形成性研究,以确定患者护理中需要改变的内容。一线医务人员,包括 8 名医生、4 名药剂师和一个多专业作者团队,提供了有关适当处方的可能障碍的见解。能力、机会、动机和行为模型以及理论领域框架用于描述行为改变干预措施,并为改变不适当处方行为提供潜在的实施干预措施。
缺乏有关处于不良结局风险患者的适当药物管理知识被认为是一个主要障碍。其他报告的障碍包括:(1)缺乏帮助药物管理的工具,(2)缺乏改变的动力,(3)缺乏常规化,以及(4)缺乏负责的临床医生。
指定一名临床医生执行逐步的、常规的护理过程,并按照清单提供的步骤进行操作,这是一种推荐的干预措施,可以克服障碍。预期的影响是减少不适当处方的行为改变。